Abstract
Background
The future remnant liver (FRL) limit for safe major hepatectomy with low risk of postoperative liver failure has not yet been well defined.
Methods
Between April 2000 and September 2004, every patient scheduled for major hepatectomy in our institution underwent CT-volumetry of FRL. Patients with FRL <25% underwent portal vein embolization (PVE). Exclusion criteria were PVE, associated vascular resection and liver cirrhosis. The FRL was correlated with short-term results in patients with normal liver (group A) and those with impaired liver function secondary to neoadjuvant chemotherapy or cholestasis (bilirubin >2 mg/100 ml) (group B). Liver dysfunction was defined as both PT <50% and serum bilirubin level >5 mg/100 ml for three or more consecutive days.
Results
A total of 119 patients were analyzed, 72 in group A and 47 in group B. The FRL value was the only significant risk factor for postoperative liver dysfunction in the univariate and multivariate analysis (p = 0.009). The FRL did not correlate with postoperative mortality and morbidity. Bilirubin and prothrombin time (PT) on days 3 and 7 were significantly correlated to FRL in both groups. In group A, patients with postoperative liver dysfunction had a FRL<30% (3 versus 0; p = 0.005). According to receiving operator characteristic (ROC) curve analysis, a FRL value of 26.5% predicted postoperative liver dysfunction with 66.7% sensitivity, 97.1% specificity, 50% positive predictive value (PPV), and 98.5% negative predictive value (NPV). In group B, patients with postoperative liver dysfunction had a FRL <35% (4 versus 0; p = 0.027). According to ROC curve analysis, a FRL value of 31.05% predicted postoperative liver dysfunction with 75% sensitivity, 79.1% specificity, 25% PPV, and 97.1% NPV.
Conclusions
Hepatectomy can be considered safe when FRL is >26.5% in patients with healthy liver and >31% in patients with impaired liver function.
Similar content being viewed by others
References
Imamura H, Seyama Y, Kokudo N, et al. (2004) Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery 135:508–517
Poon RT, Fan ST, Lo CM, et al. (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63–70
Fan ST, Lo CM, Liu CL, et al. (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330
Torzilli G, Makuuchi M, Inoue K, et al. (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Is there a way? A prospective analysis of our approach. Arch Surg 134:984–992
Jarnagin WR, Gonen M, Fong Y, et al. (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236:397–406
Ferrero A, Polastri R, Muratore A, et al. (2004) Extensive resections for colorectal liver metastases. J Hepatobiliary Pancreat Surg 11:92–96
Shoup M, Gonen M, D’Angelica M, et al. (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7:325–330
Vauthey JN, Baer HU, Guastella T, et al. (1993) Comparison of outcome between extended and nonextended liver resections for neoplasms. Surgery 114:968–975
Imamura H, Shimada R, Kubota M, et al. (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29:1099–1105
Abdalla EK, Hicks ME, Vauthey JN. (2001) Portal vein embolization: rationale, technique, future prospects. Br J Surg 88:165–175
Imamura H, Seyama Y, Kokudo N, et al. (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138:1198–1206
Capussotti L, Ferrero A, Viganò L, et al. (2006) Bile leakage and liver resection: where is the risk? Arch Surg 141:690–694
Rubbia-Brandt L, Audard V, Sartoretti P, et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460–466
Karoui M, Penna C, Amin-Hashem M, et al. (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7
Vauthey JN, Pawlik TM, Ribero D, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 24:2065–2072
Belghiti J, Hiramatsu K, Benoist S, et al. (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191:38–46
The Brisbane 2000 Terminology of Liver Anatomy and Resection. (2000) Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333–339
Wakabayashi H, Ishimura K, Okano K, et al. (2002) Application of preoperative portal vein embolization before major hepatic resection in patients with normal or abnormal liver parenchyma. Surgery 131:26–33
Azoulay D, Castaing D, Smail A, et al. (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486
Suc B, Panis Y, Belghiti J, et al. (1992) ‘Natural history’ of hepatectomy. Br J Surg 79:39–42
Vauthey JN, Chaoui A, Do KA, et al. (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512–519
Yigitler C, Farges O, Kianmanesh R, et al. (2003) The small remnant liver after major liver resection: how common and how relevant? Liver Transpl 9:S18–25
Matsumata T, Kanematsu T, Okudaira Y, et al. (1987) Postoperative mechanical ventilation preventing the occurrence of pleural effusion after hepatectomy. Surgery 102:493–497
Nagano Y, Togo S, Tanaka K, et al. (2003) Risk factors and management of bile leakage after hepatic resection. World J Surg 27:695–698
Takeda K, Togo S, Kunihiro O, et al. (2002) Clinicohistological features of liver failure after excessive hepatectomy. Hepatogastroenterology 49:354–358
Schindl MJ, Millar AM, Redhead DN, et al. (2006) The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg 243:507–514
Di Stefano DR, de Baere T, Denys A, et al. (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234:625–630
Kodama Y, Shimizu T, Endo H, et al. (2002) Complications of percutaneous transhepatic portal vein embolization. J Vasc Interv Radiol 13:1233–1237
Schindl MJ, Redhead DN, Fearon KC, et al. (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289–296
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferrero, A., Viganò, L., Polastri, R. et al. Postoperative Liver Dysfunction and Future Remnant Liver: Where Is the Limit?. World J Surg 31, 1643–1651 (2007). https://doi.org/10.1007/s00268-007-9123-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-007-9123-2